Literature DB >> 26447797

Should living kidney donors with hypertension be considered for organ donation?

Raymond R Townsend1, Peter P Reese, Mary Ann Lim.   

Abstract

PURPOSE OF REVIEW: The large number of end-stage kidney disease patients waiting for a kidney transplant often means years of delay before a suitable organ becomes available. Living kidney donors are one way to circumvent such long waiting times, and the desire to increase the pool of living kidney donors has allowed the selection of donors with hypertension. RECENT
FINDINGS: Hypertensive kidney donors, despite having larger glomeruli, and fewer glomeruli, particularly when over the age of 50 years, do well in follow-up. The data are mainly in white living kidney donors whose preexisting hypertension has been well controlled [blood pressure (BP) <140/90 mmHg] on one or two antihypertensive medications. Those selected for donation do as well as nonhypertensive donors as long they are older (age >50 years), nonobese (BMI 26-30 kg/m), and have no evidence of end-organ damage prior to donation.
SUMMARY: Although the data supporting long-term safety of nephrectomy in hypertensive donors are modest, small studies with short-term follow-up suggest no increase in the incidence of kidney disease or worsening of the control of hypertension in donors with a history of high BP.

Entities:  

Mesh:

Year:  2015        PMID: 26447797     DOI: 10.1097/MNH.0000000000000169

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  3 in total

1.  Risk of ESKD in Older Live Kidney Donors with Hypertension.

Authors:  Fawaz Al Ammary; Xun Luo; Abimereki D Muzaale; Allan B Massie; Deidra C Crews; Madeleine M Waldram; Mohamud A Qadi; Jacqueline Garonzik-Wang; Macey L Henderson; Daniel C Brennan; Alexander C Wiseman; Richard C Lindrooth; Jon J Snyder; Josef Coresh; Dorry L Segev
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-25       Impact factor: 8.237

2.  Inferior long-term allograft and patient outcomes among recipients of offspring living donor kidneys.

Authors:  J B Cohen; L Owei; D L Sawinski; P M Porrett
Journal:  Am J Transplant       Date:  2018-01-23       Impact factor: 8.086

3.  Blood Pressure and Living Kidney Donors: A Clinical Perspective.

Authors:  Anjay Rastogi; Stanley Yuan; Farid Arman; Lewis Simon; Kelly Shaffer; Mohammad Kamgar; Niloofar Nobakht; Jonathan S Bromberg; Matthew R Weir
Journal:  Transplant Direct       Date:  2019-09-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.